Ameritas Advisory Services, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1901275
LINCOLN, NE
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$167,398
-$375,594 QoQ
Shares Held
337
-72.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,411
of 1,705 holders
Holding Since
Mar 2023
8 quarters on record
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ameritas Advisory Services, LLC holds $690,036 across 47 Biotechnology names. VRTX ranks #1 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
337 | $167,398 | |
| 2 | MRNA |
Moderna, Inc.
|
1,110 | $77,733 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119 | $74,201 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
1,018 | $55,521 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
256 | $47,943 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
193 | $46,507 | |
| 7 | FATE |
Fate Therapeutics Inc
|
16,000 | $43,200 | |
| 8 | VCEL |
Vericel Corp
|
818 | $36,392 |
All Filings in VRTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $167,398 | 337 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $542,992 | 1,216 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $835,089 | 1,842 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $70,103 | 179 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $134,450 | 302 | Shares | Sole | 2025-07-21 | |
| 2024-06-30 | $590,587 | 1,260 | Shares | Sole | 2024-07-29 | |
| 2023-09-30 | $535,171 | 1,539 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $105,548 | 335 | Shares | Sole | 2023-04-28 | |
| No filing history on record for this holder in this stock. | ||||||